Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Single Tablet HIV Regimen Noninferior to Abacavir-Containing Regimen

Single Tablet HIV Regimen Noninferior to Abacavir-Containing Regimen

By

A phase 3 study evaluating HIV patients who switched to treatment with Biktarvy found this combination therapy to be statistically noninferior to a regimen containing abacavir,

FDA: Clarithromycin May Increase Long-Term Risk for Heart Problems, Death

FDA: Clarithromycin May Increase Long-Term Risk for Heart Problems, Death

By

The recommendation was made after the FDA reviewed the results of a 10-year follow-up of the CLARICOR trial, which investigated the effects of clarithromycin in patients with stable coronary heart disease.

ACIP Renews Recommendation for Flumist Quadrivalent

ACIP Renews Recommendation for Flumist Quadrivalent

By

The recommendation follows the presentation of positive results from a US study in children between the ages of 2 to <4 years evaluating the shedding and antibody responses of the H1N1 strain in the live attenuated influenza vaccine.

ACIP Votes in Favor of Heplisav-B for Hepatitis B Prevention in Adults

ACIP Votes in Favor of Heplisav-B for Hepatitis B Prevention in Adults

By

The FDA approval of Heplisav-B was based on data from 3 phase 3 noninferiority trials involving close to 10,000 adults who received the vaccine.

ACIP Recommends Third Dose of MMR Vaccine for People With Increased Risk

ACIP Recommends Third Dose of MMR Vaccine for People With Increased Risk

By

Individuals who have previously received 2 doses of a mumps-containing vaccine should receive a third dose if at increased risk for developing mumps.

More Articles by Diana Ernst, RPh

Sign Up for Free e-newsletters